Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Change in Account Payables (2020 - 2026)

Opus Genetics has reported Change in Account Payables over the past 7 years, most recently at $1.2 million for Q1 2026.

  • Quarterly Change in Account Payables rose 260.86% to $1.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2026, up 559.66% year-over-year, with the annual reading at $7000.0 for FY2025, 96.82% down from the prior year.
  • Change in Account Payables was $1.2 million for Q1 2026 at Opus Genetics, up from $804000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $1.5 million in Q4 2024 and troughed at -$1.4 million in Q2 2024.
  • The 5-year median for Change in Account Payables is $102000.0 (2023), against an average of $114647.1.
  • Year-over-year, Change in Account Payables surged 23140.0% in 2023 and then tumbled 1501.96% in 2024.
  • A 5-year view of Change in Account Payables shows it stood at -$390000.0 in 2022, then skyrocketed by 195.64% to $373000.0 in 2023, then skyrocketed by 312.6% to $1.5 million in 2024, then plummeted by 47.76% to $804000.0 in 2025, then surged by 43.66% to $1.2 million in 2026.
  • Per Business Quant, the three most recent readings for IRD's Change in Account Payables are $1.2 million (Q1 2026), $804000.0 (Q4 2025), and $906000.0 (Q3 2025).